nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—Anastrozole—breast cancer	0.235	0.332	CbGbCtD
Sulfisoxazole—CYP2C9—Idarubicin—breast cancer	0.178	0.251	CbGbCtD
Sulfisoxazole—CYP2C9—Capecitabine—breast cancer	0.0974	0.138	CbGbCtD
Sulfisoxazole—CYP2C9—Tamoxifen—breast cancer	0.0784	0.111	CbGbCtD
Sulfisoxazole—CYP2C9—Paclitaxel—breast cancer	0.061	0.0863	CbGbCtD
Sulfisoxazole—CYP2C9—Fluorouracil—breast cancer	0.0578	0.0817	CbGbCtD
Sulfisoxazole—EDNRA—mammary gland—breast cancer	0.0126	0.189	CbGeAlD
Sulfisoxazole—EDNRA—nipple—breast cancer	0.0104	0.156	CbGeAlD
Sulfisoxazole—EDNRA—endometrium—breast cancer	0.00628	0.0943	CbGeAlD
Sulfisoxazole—EDNRA—uterus—breast cancer	0.00578	0.0869	CbGeAlD
Sulfisoxazole—EDNRA—pituitary gland—breast cancer	0.00568	0.0854	CbGeAlD
Sulfisoxazole—EDNRA—adipose tissue—breast cancer	0.00566	0.085	CbGeAlD
Sulfisoxazole—EDNRA—adrenal gland—breast cancer	0.00507	0.0763	CbGeAlD
Sulfisoxazole—EDNRA—female gonad—breast cancer	0.00473	0.0711	CbGeAlD
Sulfisoxazole—CYP2C9—mammary gland—breast cancer	0.00416	0.0625	CbGeAlD
Sulfisoxazole—EDNRA—lymph node—breast cancer	0.00304	0.0457	CbGeAlD
Sulfisoxazole—Sulfamethoxazole—NAT2—breast cancer	0.00182	0.16	CrCbGaD
Sulfisoxazole—CYP2C9—female reproductive system—breast cancer	0.00172	0.0259	CbGeAlD
Sulfisoxazole—Sulfathiazole—CYP19A1—breast cancer	0.00165	0.145	CrCbGaD
Sulfisoxazole—CYP2C9—endocrine gland—breast cancer	0.00146	0.0219	CbGeAlD
Sulfisoxazole—Dapsone—NAT2—breast cancer	0.00142	0.125	CrCbGaD
Sulfisoxazole—Sulfanilamide—CA9—breast cancer	0.001	0.0881	CrCbGaD
Sulfisoxazole—Sulfamethazine—ALB—breast cancer	0.000674	0.0594	CrCbGaD
Sulfisoxazole—Sulfamerazine—ALB—breast cancer	0.000659	0.058	CrCbGaD
Sulfisoxazole—Sulfamethoxazole—PTGS1—breast cancer	0.000563	0.0496	CrCbGaD
Sulfisoxazole—Sulfamethizole—ALB—breast cancer	0.000511	0.045	CrCbGaD
Sulfisoxazole—Sulfaphenazole—CYP2D6—breast cancer	0.000453	0.0399	CrCbGaD
Sulfisoxazole—Dapsone—PTGS1—breast cancer	0.000441	0.0388	CrCbGaD
Sulfisoxazole—Sulfadiazine—CYP3A4—breast cancer	0.000425	0.0374	CrCbGaD
Sulfisoxazole—Sulfanilamide—CYP2D6—breast cancer	0.000336	0.0296	CrCbGaD
Sulfisoxazole—Sulfamethoxazole—CYP3A4—breast cancer	0.000329	0.029	CrCbGaD
Sulfisoxazole—Sulfanilamide—CYP3A4—breast cancer	0.000288	0.0254	CrCbGaD
Sulfisoxazole—Sulfamethoxazole—ALB—breast cancer	0.000287	0.0253	CrCbGaD
Sulfisoxazole—Dapsone—CYP3A4—breast cancer	0.000257	0.0227	CrCbGaD
Sulfisoxazole—Dapsone—PTGS2—breast cancer	0.000252	0.0222	CrCbGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PLA2G4A—breast cancer	0.000142	0.000662	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CSF2—breast cancer	0.000141	0.000654	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—COMT—breast cancer	0.000138	0.000643	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTP1—breast cancer	0.000138	0.00064	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—COMT—breast cancer	0.000136	0.000634	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HADHB—breast cancer	0.000136	0.000633	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTP1—breast cancer	0.000136	0.000631	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH4—breast cancer	0.000135	0.000629	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GZMB—breast cancer	0.000134	0.000625	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL2—breast cancer	0.00013	0.000607	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGTR2—breast cancer	0.00013	0.000607	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTHLH—breast cancer	0.000129	0.0006	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BMP2—breast cancer	0.000129	0.0006	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTM1—breast cancer	0.000126	0.000588	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EDNRB—breast cancer	0.000125	0.000581	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTM1—breast cancer	0.000125	0.00058	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FHL2—breast cancer	0.000124	0.000579	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PGR—breast cancer	0.000124	0.000575	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—THBS1—breast cancer	0.000123	0.000572	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP1A1—breast cancer	0.00012	0.000558	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP1A1—breast cancer	0.000118	0.00055	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FLT1—breast cancer	0.000117	0.000546	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF3—breast cancer	0.000117	0.000544	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SQSTM1—breast cancer	0.000117	0.000544	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CG—breast cancer	0.000116	0.000541	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	0.000116	0.000538	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JAG1—breast cancer	0.000115	0.000537	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH3—breast cancer	0.000115	0.000535	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PARP1—breast cancer	0.000115	0.000535	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CALCA—breast cancer	0.000114	0.000528	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RPS6—breast cancer	0.000112	0.000522	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	0.000112	0.000521	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF4—breast cancer	0.000111	0.000518	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL12—breast cancer	0.000111	0.000516	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCR4—breast cancer	0.000111	0.000516	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PAK1—breast cancer	0.000109	0.000506	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TCF7L2—breast cancer	0.000107	0.000497	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT2—breast cancer	0.000106	0.000495	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CG—breast cancer	0.000106	0.000491	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HSP90AA1—breast cancer	0.000103	0.00048	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH2—breast cancer	0.000103	0.00048	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX2—breast cancer	0.000103	0.000479	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CD—breast cancer	0.000102	0.000476	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—breast cancer	0.000102	0.000474	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRL—breast cancer	0.0001	0.000467	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AGTR1—breast cancer	0.0001	0.000467	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—breast cancer	9.94e-05	0.000463	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STK11—breast cancer	9.89e-05	0.00046	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADAM10—breast cancer	9.89e-05	0.00046	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLG—breast cancer	9.78e-05	0.000455	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT2—breast cancer	9.67e-05	0.00045	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SYNJ2—breast cancer	9.65e-05	0.000449	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF10—breast cancer	9.62e-05	0.000447	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CD—breast cancer	9.29e-05	0.000432	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDGFA—breast cancer	9.28e-05	0.000432	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFBR2—breast cancer	9.15e-05	0.000425	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ITPR1—breast cancer	9e-05	0.000419	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NDUFS3—breast cancer	8.97e-05	0.000417	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT5A—breast cancer	8.94e-05	0.000416	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB4—breast cancer	8.94e-05	0.000416	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP3—breast cancer	8.94e-05	0.000416	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CB—breast cancer	8.92e-05	0.000415	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SMAD4—breast cancer	8.66e-05	0.000403	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—MED12—breast cancer	8.62e-05	0.000401	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1R—breast cancer	8.61e-05	0.0004	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL8—breast cancer	8.57e-05	0.000399	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HES1—breast cancer	8.45e-05	0.000393	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CHST9—breast cancer	8.43e-05	0.000392	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLA2G4A—breast cancer	8.41e-05	0.000391	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NCOR1—breast cancer	8.41e-05	0.000391	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CSF2—breast cancer	8.31e-05	0.000387	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGF1—breast cancer	8.31e-05	0.000387	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—RAF1—breast cancer	8.29e-05	0.000386	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NRG1—breast cancer	8.25e-05	0.000384	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	8.24e-05	0.000383	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—H2AFX—breast cancer	8.19e-05	0.000381	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IL2—breast cancer	8.19e-05	0.000381	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—E2F1—breast cancer	8.13e-05	0.000378	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CB—breast cancer	8.1e-05	0.000377	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	8.02e-05	0.000373	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—COX11—breast cancer	7.99e-05	0.000372	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	7.86e-05	0.000366	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SPP1—breast cancer	7.82e-05	0.000364	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL8—breast cancer	7.78e-05	0.000362	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB3—breast cancer	7.73e-05	0.00036	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGFR2—breast cancer	7.72e-05	0.000359	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—breast cancer	7.62e-05	0.000355	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL2—breast cancer	7.44e-05	0.000346	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TERT—breast cancer	7.41e-05	0.000345	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CDA—breast cancer	7.31e-05	0.00034	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SHMT1—breast cancer	7.31e-05	0.00034	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	7.22e-05	0.000336	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FGFR1—breast cancer	7.19e-05	0.000335	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	7.14e-05	0.000332	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HIF1A—breast cancer	7.09e-05	0.00033	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLCO1B1—breast cancer	7.04e-05	0.000327	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC2A5—breast cancer	7.04e-05	0.000327	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LEP—breast cancer	6.92e-05	0.000322	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	6.88e-05	0.00032	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CAV1—breast cancer	6.85e-05	0.000319	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APRT—breast cancer	6.8e-05	0.000316	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KDR—breast cancer	6.78e-05	0.000315	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FASN—breast cancer	6.67e-05	0.00031	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—breast cancer	6.64e-05	0.000309	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ESR1—breast cancer	6.6e-05	0.000307	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FN1—breast cancer	6.52e-05	0.000303	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NFKBIA—breast cancer	6.45e-05	0.0003	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ANGPTL4—breast cancer	6.39e-05	0.000297	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ESRRA—breast cancer	6.39e-05	0.000297	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH1—breast cancer	6.38e-05	0.000297	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APC—breast cancer	6.24e-05	0.00029	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CG—breast cancer	6.24e-05	0.00029	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KIT—breast cancer	6.24e-05	0.00029	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGF—breast cancer	6.17e-05	0.000287	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	6.08e-05	0.000283	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPI—breast cancer	6.06e-05	0.000282	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HADHB—breast cancer	6.06e-05	0.000282	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—MAPK3—breast cancer	5.98e-05	0.000278	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—BRAF—breast cancer	5.87e-05	0.000273	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	5.8e-05	0.00027	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDH7A1—breast cancer	5.78e-05	0.000269	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDH1A1—breast cancer	5.78e-05	0.000269	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1—breast cancer	5.72e-05	0.000266	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	5.71e-05	0.000266	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT2—breast cancer	5.71e-05	0.000266	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EGFR—breast cancer	5.69e-05	0.000265	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADSL—breast cancer	5.54e-05	0.000258	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PHGDH—breast cancer	5.54e-05	0.000258	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—UMPS—breast cancer	5.54e-05	0.000258	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—FHL2—breast cancer	5.54e-05	0.000258	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NME1—breast cancer	5.54e-05	0.000258	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CD—breast cancer	5.49e-05	0.000255	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CA—breast cancer	5.44e-05	0.000253	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—BRIP1—breast cancer	5.43e-05	0.000253	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HPSE—breast cancer	5.43e-05	0.000253	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LDHB—breast cancer	5.43e-05	0.000253	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SERPINE1—breast cancer	5.43e-05	0.000252	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—KRAS—breast cancer	5.37e-05	0.00025	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOS3—breast cancer	5.18e-05	0.000241	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMMR—breast cancer	5.15e-05	0.00024	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA3—breast cancer	5.15e-05	0.00024	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCC1—breast cancer	5.15e-05	0.00024	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARGC1B—breast cancer	4.99e-05	0.000232	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CA—breast cancer	4.94e-05	0.00023	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MDM2—breast cancer	4.92e-05	0.000229	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RAF1—breast cancer	4.9e-05	0.000228	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—RELA—breast cancer	4.88e-05	0.000227	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	4.86e-05	0.000226	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	4.86e-05	0.000226	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB2—breast cancer	4.85e-05	0.000225	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MTOR—breast cancer	4.78e-05	0.000222	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CB—breast cancer	4.78e-05	0.000222	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CA9—breast cancer	4.71e-05	0.000219	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA4—breast cancer	4.71e-05	0.000219	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	4.65e-05	0.000216	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	4.6e-05	0.000214	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL8—breast cancer	4.6e-05	0.000214	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPX2—breast cancer	4.59e-05	0.000214	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA2—breast cancer	4.59e-05	0.000214	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HRAS—breast cancer	4.57e-05	0.000212	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPX4—breast cancer	4.53e-05	0.000211	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SULT1A1—breast cancer	4.53e-05	0.000211	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1B—breast cancer	4.49e-05	0.000209	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—breast cancer	4.44e-05	0.000207	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—IDH1—breast cancer	4.43e-05	0.000206	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTA1—breast cancer	4.43e-05	0.000206	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—breast cancer	4.4e-05	0.000205	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL2—breast cancer	4.39e-05	0.000204	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NAT2—breast cancer	4.38e-05	0.000204	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—breast cancer	4.37e-05	0.000203	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCND1—breast cancer	4.28e-05	0.000199	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—JUN—breast cancer	4.27e-05	0.000199	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CTNNB1—breast cancer	4.24e-05	0.000197	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MMP9—breast cancer	4.16e-05	0.000193	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1A—breast cancer	4.14e-05	0.000193	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTEN—breast cancer	4.13e-05	0.000192	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK8—breast cancer	4.04e-05	0.000188	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—breast cancer	4.03e-05	0.000188	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	3.96e-05	0.000184	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MED12—breast cancer	3.84e-05	0.000179	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DPYD—breast cancer	3.84e-05	0.000179	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SRC—breast cancer	3.83e-05	0.000178	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDOA—breast cancer	3.78e-05	0.000176	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—breast cancer	3.73e-05	0.000174	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—STAT3—breast cancer	3.7e-05	0.000172	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOA3—breast cancer	3.67e-05	0.000171	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC2A2—breast cancer	3.64e-05	0.000169	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.61e-05	0.000168	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCG2—breast cancer	3.57e-05	0.000166	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTR—breast cancer	3.57e-05	0.000166	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CPT1A—breast cancer	3.57e-05	0.000166	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK3—breast cancer	3.53e-05	0.000164	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HPGDS—breast cancer	3.5e-05	0.000163	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HBA1—breast cancer	3.48e-05	0.000162	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MYC—breast cancer	3.43e-05	0.00016	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFB1—breast cancer	3.43e-05	0.000159	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTT1—breast cancer	3.4e-05	0.000158	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ACHE—breast cancer	3.4e-05	0.000158	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGFR—breast cancer	3.36e-05	0.000156	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP17A1—breast cancer	3.21e-05	0.00015	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS1—breast cancer	3.18e-05	0.000148	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ENO1—breast cancer	3.18e-05	0.000148	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KRAS—breast cancer	3.17e-05	0.000148	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.17e-05	0.000147	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.13e-05	0.000146	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2D6—breast cancer	3.12e-05	0.000145	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOA2—breast cancer	3.06e-05	0.000142	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—FASN—breast cancer	2.97e-05	0.000138	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—BCHE—breast cancer	2.96e-05	0.000138	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC5A5—breast cancer	2.92e-05	0.000136	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CA—breast cancer	2.92e-05	0.000136	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC2A1—breast cancer	2.82e-05	0.000131	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NQO1—breast cancer	2.82e-05	0.000131	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TP53—breast cancer	2.82e-05	0.000131	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.76e-05	0.000129	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP3A4—breast cancer	2.75e-05	0.000128	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.74e-05	0.000127	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP1B1—breast cancer	2.71e-05	0.000126	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HRAS—breast cancer	2.7e-05	0.000125	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.65e-05	0.000123	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—breast cancer	2.58e-05	0.00012	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOA1—breast cancer	2.58e-05	0.00012	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—STK11—breast cancer	2.54e-05	0.000118	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP19A1—breast cancer	2.54e-05	0.000118	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.39e-05	0.000111	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—breast cancer	2.38e-05	0.000111	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—COMT—breast cancer	2.36e-05	0.00011	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTP1—breast cancer	2.35e-05	0.000109	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMOX1—breast cancer	2.32e-05	0.000108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ITPR1—breast cancer	2.32e-05	0.000108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCB1—breast cancer	2.23e-05	0.000104	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TYMS—breast cancer	2.19e-05	0.000102	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTM1—breast cancer	2.16e-05	0.000101	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.16e-05	0.000101	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NCOR1—breast cancer	2.16e-05	0.000101	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GPX1—breast cancer	2.07e-05	9.63e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP1A1—breast cancer	2.05e-05	9.54e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ERCC2—breast cancer	2.03e-05	9.46e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTHFR—breast cancer	1.91e-05	8.89e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAV1—breast cancer	1.76e-05	8.2e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.68e-05	7.84e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CG—breast cancer	1.61e-05	7.47e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CD—breast cancer	1.41e-05	6.57e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALB—breast cancer	1.39e-05	6.48e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NOS3—breast cancer	1.33e-05	6.2e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CB—breast cancer	1.23e-05	5.72e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—breast cancer	1.22e-05	5.67e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTEN—breast cancer	1.06e-05	4.95e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CA—breast cancer	7.5e-06	3.49e-05	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—breast cancer	6.13e-06	2.85e-05	CbGpPWpGaD
